| 4812 |
Dentsu Soken Inc.
|
Earnings |
|
Financial Results Presentation Materials for Q1 FY December 2026
|
Apr 28, 2026
|
| 4204 |
Sekisui Chemical Co., Ltd.
|
Share Buyback |
|
Notice Regarding the Resolution on Treasury Stock Acquisition and Cancellation of Treasury Stock
(Based on the Provisions of Article 165, Paragraph 2 of the Companies Act and Article 178 of the Companies Act)
|
Apr 28, 2026
|
| 4204 |
Sekisui Chemical Co., Ltd.
|
Earnings |
|
Fiscal Year Ending March 2026 Financial Summary [Japanese GAAP] (Consolidated)
|
Apr 28, 2026
|
| 4063 |
Shin-Etsu Chemical Co., Ltd.
|
Personnel |
|
Notice Regarding Changes of Directors (Outside Directors, Outside Audit & Supervisory Board Members)
|
Apr 28, 2026
|
| 4063 |
Shin-Etsu Chemical Company, Limited
|
Share Buyback |
|
Notice of Resolution on Matters Concerning Share Buyback (Acquisition of Treasury Stock pursuant to Article 165, Paragraph 2 of the Companies Act)
|
Apr 28, 2026
|
| 4063 |
Shin-Etsu Chemical Co., Ltd.
|
Earnings |
|
Fiscal Year Ending March 2026 Financial Summary [Japanese GAAP] (Consolidated)
|
Apr 28, 2026
|
| 4023 |
Kureha Corporation
|
Share Buyback |
|
Notice Regarding Disposal of Treasury Stock as Restricted Stock Compensation
|
Apr 28, 2026
|
| 4023 |
Kureha Corporation
|
Personnel |
|
Notice Regarding Changes in Officers
|
Apr 28, 2026
|
| 4021 |
Nissan Chemical Corporation
|
Stock Option |
|
Notice Regarding Partial Revision of Performance-Linked Stock Compensation Plan
|
Apr 28, 2026
|
| 3964 |
Aucnet Inc.
|
Strategy |
|
Notice on Expansion of Shareholder Benefit Program
~ Continued grant from 3 trading units post stock split with partial increase in points ~
|
Apr 28, 2026
|
| 3468 |
Star Asia Investment Corporation
|
Other |
|
Notice Regarding Redemption of Owned Assets (Preferred Equity Securities)
|
Apr 28, 2026
|
| 3455 |
Healthcare & Medical Investment Corporation
|
Strategy |
|
Notification Regarding Change Registration Application for Addition of Investment Advisory and Agency Business and Type II Financial Instruments Business by the Asset Management Company, and Related Organizational Changes and Appointment of Key Personnel
|
Apr 28, 2026
|
| 2972 |
Sankei Real Estate Investment Corporation
|
Earnings |
|
Notice Regarding Revision of Operating Status and Dividend Forecast for the Fiscal Year Ending August 2026
|
Apr 28, 2026
|
| 2972 |
Sankei Real Estate Investment Corporation
|
Strategy |
|
Notice Regarding Share Buyback by Capital Reduction Without Consideration
|
Apr 28, 2026
|
| 2972 |
Sankei Real Estate Investment Corporation
|
Earnings |
|
Fiscal Year Ending February 2026 Financial Summary (REIT)
|
Apr 28, 2026
|
| 2678 |
ASKUL Corporation
|
Earnings |
|
Notice of Monthly Performance for April in the Fiscal Year Ending May 2026
|
Apr 28, 2026
|
| 2664 |
Kawachi Pharmaceutical Co., Ltd.
|
Other |
|
Notice Regarding Partial Amendment of Articles of Incorporation
|
Apr 28, 2026
|
| 2664 |
Kawachi Pharmaceutical Co., Ltd.
|
Dividend |
|
Notice Regarding Implementation of Interim Dividend and Dividend Forecast
|
Apr 28, 2026
|
| 2664 |
Kawachi Pharmaceutical Co., Ltd.
|
Earnings |
|
Notice Regarding the Recording of Extraordinary Loss
|
Apr 28, 2026
|
| 2664 |
Kawachi Pharmaceutical Co., Ltd.
|
Earnings |
|
Fiscal Year Ending March 2026 Financial Summary [Japanese GAAP] (Consolidated)
|
Apr 28, 2026
|
